Stevanato Group S.p.A. (STVN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Stevanato Group(US:STVN) Seeking Alphaยท2025-09-09 20:50Core Insights - The company is on track with its targets for 2025, indicating a positive performance relative to initial expectations [1] - 2025 is a significant year for the company as it focuses on building capacity for its bio customers, highlighting strategic investments in infrastructure [1] Group 1 - The company has initiated the construction of a greenfield plant in Italy, which is part of its long-term strategy to enhance production capabilities [1] - A major investment is also planned in Fishers, outside of Indianapolis, further emphasizing the company's commitment to expanding its operational capacity [1] - The company is dedicated to executing its growth program with a focused approach [2]